What I Read This Week...

Drug companies race to fix muscle mass loss caused by Ozempic, doctors discover a new cause for women's autoimmune conditions, and Adam Neumann tries to buy back WeWork

Read our AI Deep Dive Watch All-In E165 Listen to Our Discussion About AI Hardware Caught My Eye… Drug companies, nutrition startups and gyms are racing to offer solutions to muscle mass loss caused by weight-loss drugs like Ozempic. While GLP-1s, the current class of weight-loss drugs offered by companies like Novo Nordisk, can help patients rapidly lose weight and steer off cravings, much of this weight loss is often in the form of lean muscle mass which risks accelerating frailty in older patients. While drug companies are trying to develop solutions to this issue, doctors are…

related reading

• The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com
• Corporate Ozempic. If you want to understand how AI is… | by Scott Galloway | Mediummedium.com
• What I Read This Week...chamath.substack.com
• What I Read This Week...chamath.substack.com
• Articles — Asimov Presspress.asimov.com
• What I Read This Week…chamath.substack.com
• Semaglutide & Its Friendspanpharmacon.substack.com
• What I Read This Week…chamath.substack.com
• What I read this week...chamath.substack.com
• What I Read This Week...chamath.substack.com
• What I Read This Week…chamath.substack.com
• What I Read This Week...chamath.substack.com